Irradiation WG Updates

Slides:



Advertisements
Similar presentations
Blood Product Reimbursement Report 4 th QuarterNovember 2009Volume 1, Number This information is provided as a service to assist hospitals and other.
Advertisements

Calice Meeting DESY 13/2/07David Ward Guidelines for CALICE presentations Recently approved by the Steering Committee.
1 Quality Control Procedures During Autotransfusion AmSECT New Advances in Blood Management Meeting Seattle, Washington September 8, 2011John Rivera.
Background Methods Results Conclusion Acknowledgements Printed by Multi-Institutional Audit of octaplex® & Comparison with National Recommendations S.
Right Patient, Right Blood
Alliance for the Prevention of Chronic Disease Conference Healthier Nutrition for Kids February 24, 2011 Office of Nutrition Policy and Promotion Health.
Market Meeting Support Susan Munson ERCOT Retail Market Liaison Commercial Operations Subcommittee (COPS) June 10, 2008.
Evidence Based Medication Use in the NICU: Erythropoietin Dan Ellsbury MD Director, Continuous Quality Improvement Pediatrix Medical Group.
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
Dispensary and Administration Site Information Presentation.
1 The GCC Metrology Group GULFMET Mohammad Al Mulla GSO - Building for Integration
The Challenge Posting Process Using the Loft Platform.
New policy starts 5th April 2016 IMPORTANT CHANGE TO BLOOD TRANSFUSION SAMPLE REQUIREMENTS Confirmation of a blood group from two samples taken on separate.
Preparation of the Self-Study and Documentation
CSTM Annual Conference
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Explorer Post Renewal Instructions
Designing Effective Accommodation Plans in Clinical Placement & Internship Settings
Platelet outdates Kathryn Webert
Utilization of O-Rh-Negative Red Cells
Climate Change Resiliency Planning in Canadian Hospitals
Stroke Advisory Council Meeting
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
Support- IRDiRC Proposed Work Plan And Communication Strategy
Interrater agreement and time it takes to assign a Canadian Triage and Acuity Scale score in 7 emergency departments McLeod, S.L.1,2 McCarron, J.3 Stein,
Meeting Procedure.
Major Information Session Medical Dietetics
How Volunteers Can Impact Patient Safety
NAC Irradiation Working Group
Manitoba Report for NAC April 28-29, 2016
NAC Update: British Columbia
Seed Dust Working Group
Part C State Performance Plan/Annual Performance Report:
O Neg RBC Audit 2013 (Jan Feb Mar) 3735 AVG N=34 28 (0.7%) 408 (11.0%)
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
Manitoba Report for NAC October 15,
Health Canada’s Collaboration with the NAC – Provincial TM Network
Blood Shortages Working Group
Presented by: Ramzi Thabit, November 24th, 2016
Wendy Peppel Lead Senior Manager National Blood File Dr. Angela Tonary
Alberta Health Services
Transplant Administrators Committee (TAC)
BASIC IRRS TRAINING Lecture 14
Blood Shortage Working Group
Joint WG on Guidance for an Integrated Transport and Storage Safety Case for Dual Purpose Casks TM TM to Produce Consolidated Drafts of the IAEA’s.
CNISP & CIHI MRSA infection rate comparison Preliminary results
Presented by Dr. Susan Nahirniak November 06th 2014
SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS
NAC meeting April 30-May 1, 2014.
NAC National Advisory Committee Canadian Blood Services Review of Select Distribution Trends April 25, 2013 Toronto Rick Trifunov Director, Plasma.
PSO Overview for (name of organization’s) PSES Workgroup
Nova Scotia Update NAC Meeting October 15-16, 2015.
PT CBS BLC Updates NAC Face to Face Bernadette Muise
IESBA Meeting New York September 17-20, 2018
Consideration of reducing the shelf life of SAGM RBCs
Update – D Morrison October 15, 2015
CMV Working Group Update to NAC April 2016.
NAC Irradiation Recommendations: Update
Joint (PT CBS BLC and NAC) Meeting
Trace Line Project Realizations NAC Meeting
Irradiation Survey Purpose: To further confirm variability in the provision of irradiated blood components to patients across the country (NAC discussion.
West Essex Business Planning Process
TOP6 – WP4 Coordination and Management JPICH Coordination Office
PSO Overview for Executives
Overview US Paper C2-7.INF
Introduction to Transfusion: Ordering Blood Products
PSO Overview for (name of organization’s) PSES Workgroup
TOP6 – WP4 Coordination and Management JPICH Coordination Office
Multijurisdictional FAQs (Workshop Stream 3)
Guidelines for exchange transfusion in infants 35 or more weeks’ gestation.Note that these suggested levels represent a consensus of most of the committee.
Presentation transcript:

Irradiation WG Updates Presented by Debra Lane, MD on behalf of the Irradiation WG April 16th, 2015

Irradiation Guidelines NAC Draft Irradiation Guidelines have been resurrected due to: An interest in changing the CSA standard around irradiation parameters so that the standards reflect the European practice that is more appropriate for SAGM red cells. An official request from the PT CBS BLC for NAC to perform Irradiation recommendations was received November 3rd, 2014.

Irradiation Guidelines At the November F to F meeting (2014) it was decided that since the BC guidelines have been generated it would be prudent to compare the Draft National Advisory Committee’s Recommendations for use of Irradiated Blood Components against the BC Provincial Guidelines for agreement, gaps, etc.

Irradiation Guidelines Irradiation WG formed - first meeting held January 29th, 2015. Members: Doug Morrison - Irradiation WG Chair Dr. Dana Devine Dr. Debra Lane Dr. Brian Muirhead – NAC Chair Dr. Susan Nahirniak Dr. Lakshmi Rajappannair

Irradiation Guidelines WG agreed to extend the scope of NAC’s guidelines to include storage conditions of Red Blood Cells post irradiation: Concern raised is the fact that the guidelines in use in Canada are not aligned with the type of RBCs currently produced by CBS; saline-adenine-glucose-mannitol (SAGM) since converting to the Buffy Coat manufacturing process. Also noted the importance to include post storage recommendations since the Canadian Standards (CSA) group cannot get changes to take effect until the next iteration of the standard. It is also for the best interest of patient safety to change storage conditions noting that Irradiation guidelines may put more impetus on Health Canada to accept some of the recommendations of the CSA WG if sites are already following set recommendations.

Irradiation Guidelines A comparison table of the 2 guidelines was prepared by Veronica Woo – Project Coordinator @BC Provincial Blood Coordinating Office (PBCO). Members agreed that no further review required for those areas where both documents are in alignment . Indications that had slight and major differences were reviewed and discussed individually.  

Irradiation Guidelines The indications requiring further actions/discussions by members are: Acute Leukemia Non Hodgkin lymphoma (NHL), myeloma and chronic lymphoproliferative disorders Neonatal Exchange Transfusions (with no previous IUT ) Congenital heart defects in neonates and young infants One indication (Neonatal TOP UP Transfusion) requires data gathering for further investigation.

Neonatal Top Up Transfusions BC Guidelines All routine neonatal 'top-up' transfusions of neonates (< 4 months of age) with very low birth weights (VLBW) of <1,200 g should receive irradiated cellular components. Recognizing, that VLBW neonates comprise the vast majority of neonates who require transfusion, it is reasonable to establish a hospital specific policy to irradiate for all neonatal top-up transfusions, purely from a logistical perspective. NAC Draft Guidelines Presently no direction provided Requires data gathering; draft survey compiled for review.

Survey - Neonatal Top Up Transfusions In the absence of evidence a survey has been drafted to gather data Are irradiated cellular blood components provided for any of the following: Intrauterine transfusions Post partum top ups after an intrauterine transfusion Post partum exchange transfusions after an intrauterine transfusion Top up transfusions for all neonates (0-4 months) Top up transfusions for neonates less than 1200 grams Exchange transfusion in neonates

Neonatal Top Up Transfusions Are cellular blood components for neonates leukoreduced? 2a. If yes (Q #2) is it done at bedside or at the production stage (prestorage)? 3. Do you think that irradiation can be abandoned in the context of (universal) pre- storage leukoreduction for any of the clinical scenarios outline in question #1? 4. Do you think clinicians would accept a policy of not irradiating pre-storage leukoreduced cellular blood components for any of the clinical scenarios outlined in question #1?

Neonatal Top Up Transfusions Do you think additional studies are needed to improve strategies for preventing the usage of irradiation? 5b. If yes, (Q #5) please indicate your suggestions (systematic review, consensus conference, etc.). Is irradiation done on site at your hospital? 6b. If not,(Q #6) is there a manipulation to reduce the levels of K+?

Neonatal Top Up Transfusions 7. Has your institution been notified of a case of TAGvHD in a neonate? What is the annual number of neonates transfused with cellular blood components? (separate RBC and platelets) 9. What is the annual number of neonates transfusion events with cellular blood components? (separate RBC and platelets)

Irradiation Guidelines Next Steps: NAC Coordinator is to compile a list of Hospitals/Contact info for hospitals in Canada and the USA (with a level 3 or higher nursery). Once survey is finalized, NAC Coordinator to send survey to identified contacts and tabulate findings. Invite CCMNT members to collaborate with the NAC Irradiation WG?

Irradiation Guidelines